 A STUDY OF RO7123520 TO EVALUATE THE SAFETY AND EFFICACY IN PARTICIPANTS WITH MODERATELY TO SEVERELY ACTIVE RHEUMATOID ARTHRITIS RA WHO ARE INADEQUATELY RESPONDING TO ANTI-TUMOR NECROSIS FACTOR TNF-ALPHA THERAPY: 